All In MedTech

Device Trial Radar · NCT07057206

Simultaneous Engagement of Networks for Alleviating Pain (SENAP)

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jan 1, 2027

Primary completion

Dec 2030

Study completion Dec 2030

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 9, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is investigating the acceptability and efficacy of PFM-guided cortical stimulation for the treatment of central neuropathic pain.

Conditions

  • Neuropathic Pain
  • Postherpetic Neuralgia

Interventions

  • PFM-guided cortical stimulationDevice

    Abbott Eterna IPG and Lamitrode 44 paddles with accessory extensions and clinical programmers

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. FeasibilityTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Minnesota

    Minneapolis, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.